16-21984595-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001363519.1(PDZD9):āc.467T>Cā(p.Val156Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000645 in 1,550,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001363519.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDZD9 | NM_001363519.1 | c.467T>C | p.Val156Ala | missense_variant | 4/4 | ENST00000424898.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDZD9 | ENST00000424898.3 | c.467T>C | p.Val156Ala | missense_variant | 4/4 | 5 | NM_001363519.1 | P1 | |
PDZD9 | ENST00000523914.5 | c.*244T>C | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 1 | ||||
PDZD9 | ENST00000537222.6 | c.287T>C | p.Val96Ala | missense_variant | 3/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000919 AC: 2AN: 217680Hom.: 0 AF XY: 0.0000170 AC XY: 2AN XY: 117580
GnomAD4 exome AF: 0.00000572 AC: 8AN: 1397842Hom.: 0 Cov.: 30 AF XY: 0.00000728 AC XY: 5AN XY: 686490
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 12, 2023 | The c.287T>C (p.V96A) alteration is located in exon 3 (coding exon 3) of the PDZD9 gene. This alteration results from a T to C substitution at nucleotide position 287, causing the valine (V) at amino acid position 96 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at